Evidence map›Paper›PMID 24465494›Full record

ArticlePloS one2014

Global state measures of the dentate gyrus gene expression system predict antidepressant-sensitive behaviors.

Benjamin A Samuels, E David Leonardo, Alex Dranovsky, Amanda Williams, Erik Wong, Addie May I Nesbitt, Richard D McCurdy, Rene Hen, Mark Alter

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Rodent models of treatment-resistant depression.European journal of pharmacology · 2015
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Benjamin A SamuelsDepartments of Psychiatry and Neuroscience, Columbia University, New York, New York, United States of America.
E David LeonardoDepartments of Psychiatry and Neuroscience, Columbia University, New York, New York, United States of America.
Alex DranovskyDepartments of Psychiatry and Neuroscience, Columbia University, New York, New York, United States of America.
Amanda WilliamsAstraZeneca Pharmaceuticals, CNS Discovery, Wilmington, Delaware, United States of America.
Erik WongAstraZeneca Pharmaceuticals, CNS Discovery, Wilmington, Delaware, United States of America.
Addie May I NesbittCenter for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Richard D McCurdyCenter for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Rene HenDepartments of Psychiatry and Neuroscience, Columbia University, New York, New York, United States of America.
Mark AlterCenter for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Columbia University · USUniversity of Pennsylvania · USAstraZeneca (United States) · US

Funding

TRAINING PROGRAM IN NEUROPSYCHOPHARMACOLOGY-PREDOCTORALT32MH014654 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 1985 to 2021
$5.0M
Cellular Mechanisms of Antidepressant ActionR37MH068542 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HEN, RENE · 2008 to 2017
$4.1M
Mechanisms and Significance of Stem Cell Fate Plasticity in the Adult HippocampusR01MH091844 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI DRANOVSKY, ALEX · 2010 to 2014
$2.0M
A Late Sensitive Period for the Development of Anxiety DisordersR01MH091427 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI LEONARDO, EDUARDO DAVID · 2010 to 2014
$2.0M
Hippocampal neurogenesis, pattern separation & age-related cognitive impairments.R01AG043688 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FENTON, ANDRE ANTONIO, HEN, RENE · 2013 to 2017
$1.6M
Hippocampal Neurogenesis: Mechanisms of Antidepressant ActionK08MH076083 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEONARDO, EDUARDO DAVID · 2006 to 2010
$952k
How the Large-Scale Organization of Gene Expression Relates to Behavior in MiceK08MH080228 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ALTER, MARK D · 2009 to 2013
$886k
Mechanisms Underlying Treatment-Resistant Depression and Anxiety in Mouse ModelsK01MH098188 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI SAMUELS, BENJAMIN A · 2012 to 2014
$517k
NIA NIH HHS R01 AG043688NIMH NIH HHS 1K01MH098188-01NIMH NIH HHS 1K08MH076083NIMH NIH HHS 1K08MH080228-04NIMH NIH HHS 1R01MH091427NIMH NIH HHS K01 MH098188NIMH NIH HHS K08 MH076083NIMH NIH HHS K08 MH080228NIMH NIH HHS R01 MH091427NIMH NIH HHS R01 MH091844NIMH NIH HHS R37 MH068542NIMH NIH HHS T32 MH014654
6 · The paper itself

Abstract

backgroundSelective serotonin reuptake inhibitors (SSRIs) such as fluoxetine are the most common form of medication treatment for major depression. However, approximately 50% of depressed patients fail to achieve an effective treatment response. Understanding how gene expression systems respond to treatments may be critical for understanding antidepressant resistance.

methodsWe take a novel approach to this problem by demonstrating that the gene expression system of the dentate gyrus responds to fluoxetine (FLX), a commonly used antidepressant medication, in a stereotyped-manner involving changes in the expression levels of thousands of genes. The aggregate behavior of this large-scale systemic response was quantified with principal components analysis (PCA) yielding a single quantitative measure of the global gene expression system state.

resultsQuantitative measures of system state were highly correlated with variability in levels of antidepressant-sensitive behaviors in a mouse model of depression treated with fluoxetine. Analysis of dorsal and ventral dentate samples in the same mice indicated that system state co-varied across these regions despite their reported functional differences. Aggregate measures of gene expression system state were very robust and remained unchanged when different microarray data processing algorithms were used and even when completely different sets of gene expression levels were used for their calculation.

conclusionsSystem state measures provide a robust method to quantify and relate global gene expression system state variability to behavior and treatment. State variability also suggests that the diversity of reported changes in gene expression levels in response to treatments such as fluoxetine may represent different perspectives on unified but noisy global gene expression system state level responses. Studying regulation of gene expression systems at the state level may be useful in guiding new approaches to augmentation of traditional antidepressant treatments.

Indexed as

Behavior, AnimalGene Expression RegulationAnimalsAntidepressive AgentsDentate GyrusDepressionDisease Models, AnimalFluoxetineMaleMiceMice, Inbred C57BLPrincipal Component AnalysisReproducibility of ResultsSignal TransductionAntidepressive AgentsFluoxetine

Identifiers

PMID24465494
PMCPMC3894967
OpenAlexW1995818832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.